Career summary

Prof Doran holds a Bachelor of Economics (Honours), a PhD in Health Economics and is a recent graduate of the Australian Institute of Company Directors. His main area of research is mental health with a focus on substance use and suicidal behaviour. Chris is a Professor of Health Economics in the Centre for Indigenous Health Equity Research, Central Queensland University (CQUniversity).

Research output (2013-17)

Prof Doran’s output as a researcher has been outstanding with evidence of a rising trajectory in terms of policy relevance, leadership, grants, manuscripts and impact. Over the 5-year period 2013-17, he has been an investigator on 39 competitive grants valued at $30.4 million including 15 NHMRC grants. Prof Doran has led world class research in the area of health economics through NHMRC funded (APP 456002, APP630441), and other funded research. He currently leads the health economic component in: 3 centres of research excellence (APP1117198, APP1078579, APP1078927); 4 partnership grants (APP1114511, APP1113693 APP1112983, APP1077036); and, a number of other global, targeted, dementia and project grants. Over the 5-year period 2013-17, he has published 65 peer-reviewed manuscripts (average of 13 per year) and produced 26 policy relevant reports.

Contribution to field of research

Prof Doran’s research has contributed to the field of health economics and strengthened the evidence base for effective policy action. In recent years, his focus on priority setting has been complemented with the development of tools and frameworks to facilitate translational research. His translational research has contributed to the development, implementation and evaluation of national and international substance abuse and mental health policies.

Collaborations

A major strength of Prof Doran’s research is the network of collaborations he has established. Evidenced by his research output, Prof Doran has collaborated extensively with academics, consumer groups, practitioners and policy makers in building capacity in the knowledge, use and translation of health economics. Due to his globally recognised research into the health economics of mental health and substance abuse, he has developed strong links with the World Health Organisation and the United Nations Office on Drugs and Crime, leading to invited presentations, collaborative manuscripts, commissioned research and a sabbatical placement with the World Health Organisation in Geneva. His research projects are multi-disciplinary, multi-institutional with a strong focus on collaboration and capacity building. For example, as CI on APP351558, he worked closely with members of the steering and advisory committees representing 5 universities, state and federal government organisations, non-government organisations, community and Indigenous experts and the World Health Organisation.

International standing

Prof Doran’s current research is well regarded internationally, acknowledged by commissioned research from the World Health Organisation, the United Nations, Mental Health Commissions’, Industry and requests to serve on prestigious journal and grant review committees. His latest research for the United Nations examined the economic cost of addiction in the United Arab Emirates and was published in the Eastern Mediterranean Health Journal. He has recently (February 2018) been invited, by the United Nations, to conduct a similar study in Kuwait.

· Bachelor of Economics (Honours), Faculty of Economics, University of Newcastle, conferred 1993.

· Doctor of Philosophy – Health Economics (Ph.D.), Faculty of Medicine and Health Sciences, Faculty of Economics, University of Newcastle, conferred 1999.

November 2015 - Current

· Professor Health Economics, Central Queensland University

· Adjunct Professor University of Newcastle (New South Wales)

· Adjunct Professor Edith Cowan University (Western Australia)

January 2011 – October 2015

· Director - Health Research Economists Unit, Hunter Medical Research Institute (HMRI)

· Adjunct Professor University of Newcastle (New South Wales)

· Adjunct Professor Edith Cowan University (Western Australia)

February 2008 – January 2011

· Associate Professor of Health Economics, National Drug and Alcohol Research Centre (NDARC), University of New South Wales

· Assistant Director February 2008 – January 2011

September 2003 – January 2008

-Associate Professor / Health Economist, Centre for Burden of Disease and Cost-Effectiveness, School of Population Health (80%), School of Economics (20%), University of Queensland

January 2000 – August 2003

- Health economist, National Drug and Alcohol Research Centre (NDARC), UNSW

July 1999 – December 1999

- Post-doctoral research fellow, School of Population Health, University of Newcastle.

· 2017. CQUniversity Opal award for engaged research and innovation. Brisbane, Queensland.

· 2016 and 2017. National Health and Medical Research Centre – panel member assessing applications for centres of research excellence in the clinical stream.

· 2016. Invited by Professor Allan Fels to participate in the National Mental Health Commission workshop on economics of mental health. Melbourne, December 2016.

· 2015. Nominated for NSW Premier’s Award for Excellence in Translational Cancer Research. Hosted by Cancer Institute of New South Wales.

· 2013. National Drug and Alcohol Awards. Excellence in Services for Young People Award: Beat the Binge project in Yarrabah Indigenous community Far north Queensland.

· 2013. National Drug and Alcohol Awards. Excellence in Research: Alcohol Action in Rural Australian Communities. Highly Commended Award.

· 2013. Australian National Preventative Health Agency. Finalist: Translation Research Award. Alcohol Action in Rural Australian Communities.

· 2012. Australasian Society for Intellectual Disability Australasian research paper of the year: How much does intellectual disability really cost – first estimates for Australia.

· 2011. National Drug and Alcohol Awards. Excellence in Research: The Range and Magnitude of Alcohols' Harm to Others.

· 2010. Travelling fellowship. Cairns Institute, James Cook University.

· 2006. Mentor for the Interdisciplinary Postgraduate Training in Mental Health Policy and Economic Research, conferred by the World Psychiatric Association in conjunction with the International Centre of Mental Health Policy and Economics.

· 1996. Award for excellence in student research, 10^th world conference on Tobacco or Health, Beijing.

· 1995. Australian Postgraduate Research Scholarship.

Co-ordination

· For the period 2003 – 2008, I was the program co-ordinator for the Graduate Certificate, Graduate Diploma and Masters of Health Economics at the University of Queensland.

o Responsibilities included: daily operation of the teaching program; administrative duties; and, development of new courses.

o In 2006 I revised the entire Master of Health Economics program to make entry requirements more flexible and develop areas of specialisation - these modifications were ratified in 2007.

· For the period 2006-08, I was the course co-ordinator for: Economic Evaluation in Health, Pharmacoeconomics, Cost-effectiveness in Health and Medicine, and Health and Development.

o As course coordinator I was directly responsible for: development of course profiles; maintaining blackboard sites (i.e., a web-based teaching aid to students), and, assessment, including the development and running of tutorials, setting and marking assignments, setting and marking exams.

· In 2008 I was involved in developing the curriculum for a dual Masters degree in Health Economics and Public Health, the first initiative in the world.

Lecturing

- For the period 2003-08, I lectured in: Economic Evaluation in Health, Pharmacoeconomics, Cost-effectiveness in Health and Medicine, Health and Development, Health Management, Health Economics and Policy.

· Australian Institute of Company Directors

· International Health Economics Association

· Australian Health Economics Association

· Editorial board of Applied Health Economics and Health Policy

· Editorial board PLOS One

· Editorial board of Journal of Addiction & Therapy

· United Kingdom National Health Service National Institute of Health Research Dissemination Centre College of Raters

· World Suicidality Net

· CQU Professoriate

· CQU Academic Board

Major research achievements

· Since 2000, a total of 159 publications, 53 reports and 3 book chapters. For the 5-year period 2013-2017, a total of 65 publications (average of 13 per year). A further 14 manuscripts are currently under review at a peer-reviewed journal.

· Seminal contributions include:

o a WHO Bulletin paper that introduces a Country level instrument to aid the development of alcohol policy;

o a Lancet paper that influenced an Australian Senate Affairs Inquiry into alcohol taxation;

o a manuscript on the economic cost of traumatic brain injury that was used by the Vietnamese National Assembly in mandating helmet use for motor bike users;

o a manuscript that outlines clinical guidelines for the treatment of post-traumatic stress in Australian clinical practice;

o a manuscript that introduced an instrument to evaluate empowerment in Indigenous Australians; and,

o various research papers that has led to the improvement of health care resource allocation in Australia.

· Since 2000, an investigator on 82 competitive grants valued at $63.79 million. A chief investigator on 75 grants valued at $51.86 million: 31 NHMRC grants; 5 from the Cancer Council; 3 international philanthropic grants; 4 ARC grants; and several grants from the Commonwealth of Australia and the Cancer Institute of NSW. An associate investigator on another 7 grants (all NHMRC grants) valued at $11.93 million.

· Significant grants include:

o Chief investigator on a $1.9 million NHMRC capacity building grant in health economics;

o Chief investigator on a $3.3 million NHMRC health services research grant entitled “Assessing cost effectiveness of interventions to reduce the burden of harm from non-communicable diseases (NCDs)”. This research is the largest and most rigorous cost-effectiveness analysis of preventive strategies ever undertaken.

o Chief investigator on a $600,000 NHMRC project grant identifying cost-effective strategies to address alcohol-related harm in Indigenous communities;

o Chief investigator on a $4 million Atlantic Philanthropies funded grant building the evidence base for health policy in Vietnam; and,

o Chief investigator on a $2.3 million randomised controlled community trial focused on addressing alcohol harm in rural communities.

Major policy achievements

· Collaborated with several Queensland based Primary Health Networks on strategic direction related to mental health and drug and alcohol use.

· Collaborated with Cancer Institute of New South Wales to develop estimates of the cost of skin cancer and the economic benefit of mass media skin cancer prevention campaigns.

· Part of the research team that developed the first research tool to measure levels of empowerment among Indigenous people.

· Led the economic evaluation of the largest randomised clinical trial of buprenorphine versus methadone, a pivotal study for the United States Federal Drug Advisory registration of buprenorphine.

· Contributor to the development and implementation of International policies to address illicit drugs, tobacco and research through my research and direct collaboration with the World Health Organisation and the United Nations Office on Drugs and Crime.

· Contributor to the development and implementation of alcohol policy in Australia through research outcome and presentations to the NAAA Alcohol Tax Forum and the Senate Affairs Committee Inquiry into Excise Tariff Amendment (2009 Measure No. 1) Bill 2009 and Customs Tariff Amendment (2009 Measure No. 1) Bill 2009.

· Contributor to enhancing evidence base on use of complementary medicines in Australia through research and advice to National Complementary Medicine Reference Group.

· Development of policy action to address tobacco use in Singapore through my involvement with the Singapore Health Promotion Board, Ministry of Health.

· Development of policy action to address tobacco and alcohol use in Vietnam through my involvement with various Vietnamese institutions including: Hanoi School of Public Health, Health Strategy and Policy Institute, Hanoi Medical University and Hue Medical University.

1. Bailie, J., Laycock, A., Bailie, R. Signatories included Bainbridge, R., Doran, C., McCalman, J. CRE-IQI Submission to Closing the Gap Refresh https://closingthegaprefresh.pmc.gov.au/sites/default/files/submissions/cre-iqi.pdf;

2. Shakeshaft A, Clifford A, James D, Doran C, Munro A, Patrao T, Bennett A, Binge C, Bloxsome T, Coyte J, Edwards D, Henderson N, Jeffries D. 2018. Understanding clients, treatment models and evaluation options for the NSW Aboriginal Residential Healing Drug and Alcohol Network (NARHDAN): a community-based participatory research approach. Prepared by the National Drug and Alcohol Research Centre (UNSW Sydney) for the Department of the Prime Minister and Cabinet, Canberra ACT.

3. Shakeshaft AP, Doran CM. (2017).Future directions for social housing in New South Wales, Australia. An evaluation framework. An evaluation framework developed for New South Wales Family and Community Services.

4. Doran CM, Kinchin I. (2017). Economic assessment of creating a mentally health workforce. A review conducted for the National Mental Health Commission.

5. DORAN CM, Kinchin I. (2017). Economic Evaluation Protocol of the INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL – MCRPC): A Multicenter, Randomized, Controlled, Phase III Study. Prepared for Movember Foundation, Brisbane.

6. Doran CM, Kinchin I, Bainbridge R, McCalman J, Shakeshaft AP. Effectiveness of alcohol and other drug interventions in at risk Aboriginal youth: an Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the NSW Drug and Alcohol Population and Community Programs, 2017.

7. Browne M, Greer N, Armstrong T, DORAN CM, Kinchin I, Langham E & Rockloff M. (2017). The Social Cost of Gambling to Victoria. Victorian Responsible Gambling Foundation, Melbourne.

8. DORAN CM, Kinchin I. (2016). Economic Evaluation Protocol of the INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL – MCRPC): A Multicenter, Randomized, Controlled, Phase III Study. Prepared for Movember Foundation, Brisbane.

9. Reeves P, Ling R, DORAN CM. (2016). Partners in recovery economic evaluation. Report prepared for the South East Sydney Medicare Local. Newcastle.

10. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the New South Wales Construction Industry. Report prepared for Mates in Construction, Brisbane.

11. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Queensland Construction Industry. Report prepared for Mates in Construction, Brisbane.

12. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Western Australian Construction Industry. Report prepared for Mates in Construction, Brisbane.

13. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Northern Territory Construction Industry. Report prepared for Mates in Construction, Brisbane.

14. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the South Australian Construction Industry. Report prepared for Mates in Construction, Brisbane.

15. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Tasmanian Construction Industry. Report prepared for Mates in Construction, Brisbane.

16. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Australian Capital Territory Construction Industry. Report prepared for Mates in Construction, Brisbane.

17. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Victorian Construction Industry. Report prepared for Mates in Construction, Brisbane.

18. DORAN CM, Ling R. (2015). A rapid review of the net costs of clinical trials in NSW. Report prepared for the Cancer Institute New South Wales, Sydney.

19. Deeming S, DORAN CM, Paul C. (2015). Modelling the impacts of reducing tobacco retail availability (density, proximity and structure) on smoking behaviours in NSW. Reports prepared for the Cancer Council of New South Wales, Sydney.

20. DORAN CM, Ling R, Milner A. (2015). The economic cost of suicide in the Australian Construction Industry. Report prepared for Mates in Construction, Brisbane.

21. Gibson P, Marks G et al. Case for Action proposal: Targeted therapy for asthma. Submitted by the NHMRC Research Translation Faculty Asthma Steering Group; February 2015. Available at: www.nhmrc.gov.au/research/research-translation/research-translation-faculty/ideas-research-translation-faculty-cases.

22. DORAN CM. (2014). Economic burden of drug addiction in the United Arab Emirates. Report prepared for the United Nations Office on Drugs and Crime, Abu Dhabi.

23. DORAN CM, Ling R. (2014). The economic cost of suicide and suicide behaviour in the NSW Construction Industry and the potential impact of Mates in Construction suicide prevention strategy in reducing this cost. Report prepared for Mates in Construction, Brisbane.

24. DORAN CM, Ling R, Byrnes J, Searles A, Shakeshaft AP, Crane M, Perez D, Kite J. (2014). Economic analysis of the social costs of skin cancer in New South Wales, 2010. Report prepared for the Cancer Institute of New South Wales, Sydney.

25. DORAN CM, Ling R, Byrnes J, Searles A, Shakeshaft AP, Crane M, Perez D, Warner-Smith M. (2014). Benefit cost analysis of three Cancer Institute New South Wales mass-media skin cancer prevention campaigns – 2006/7 – 2012/13 summer period. Report prepared for the Cancer Institute of New South Wales, Sydney.

26. Darke S, Shakeshaft AP, DORAN CM (2013). Alcohol and violence: alcohol consumption, homicide and completed suicide in Australia, 1979-2009. National Drug and Alcohol Research Centre Technical Report No. 324.

27. DORAN CM (2013). A rapid review of the evidence on the costs and impacts on the economy and productivity due to mental ill health. Report prepared for the Mental Health Commission of NSW, March 2013.

28. DORAN CM (2013). A rapid review of the evidence on the costs and benefits of interventions for mental illness. Report prepared for the Mental Health Commission of NSW, March 2013.

29. DORAN CM, Ling R. (2012). Identification of data sources to measure project outcomes related to Central Land Council Community Development Projects. Report prepared for the Northern Territory Central Land Council, Alice Springs, December 2012.

30. Searles A, McCalman J, Tsey K, DORAM CM, Shakeshaft AP. (2012). Evaluating health initiatives in Cape York Indigenous Communities: A scoping document. Report prepared for Queensland Health, Brisbane, October 2012.

31. Searles A, Whiteside M, McCalman J, Tsey K, DORAN CM. (2012). Evaluation of the Family Wellbeing initiative delivered to Safe-House staff. Report prepared for ACT for Kids, Brisbane, October 2012.

32. Doran CM, Searles AP. (2011). The economic costs and benefits of a co-operative research centre in prostate cancer. Melbourne: Australian Prostate Cancer Research Centre.

33. Shakeshaft AP, Doran CM, Petrie D, Abudeen A, D’Este C, Breen C, Clifford A, Havard A, Wood E, Sanson-Fisher R. (2011). The alcohol action in rural communities (AARC) project: working with communities to select, implement and measure the impact of strategies to reduce alcohol-related harm. Canberra: Alcohol Education and Rehabilitation Foundation.

34. Tam NM, Lan NH, Doran CM, et al., editors. Assessing cost-effectiveness (ACE) of interventions to reduce burden of harm from alcohol misuse in Viet Nam: developing the evidence base for health policy in Viet Nam. Hanoi: Health Strategy and Policy Institute, 2011

35. Doran CM, Byrnes J, Vos T, Cobiac L, Petrie D, Calabria B (2011). Strengthening the evidence base for volumetric taxation of alcohol in Australia. Carlton: Victorian Health Promotion Foundation (VicHealth).

36. Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman JL, Magnus A, Cobiac L, Bertram MY, Wallace AL, ACE–Prevention Team (2010). Assessing Cost-Effectiveness in Prevention (ACE–Prevention): Final Report. University of Queensland, Brisbane and Deakin University, Melbourne.

37. Peterson et al (2010). The role of community pharmacy in post hospital management of patients initiated on warfarin. Canberra: Pharmacy Guild of Australia.

38. Peterson et al (2010). Documenting Clinical Interventions in Community Pharmacy. Canberra: Pharmacy Guild of Australia.

39. Doran CM, Cobiac L, Byrnes J, Vos T. (2010). Alcohol taxation and distribution of gains. Carlton: Victorian Health Promotion Foundation (VicHealth).

40. Laslett A-M, Catalano P, Chikritzhs Y, Dale C, Doran CM, Ferris J, Jainullabudeen T, Livingston M, Matthews S, Mugavin J, Room R, Schlotterlein M, Wilkinson C (2010). The Range and Magnitude of Alcohol’s Harm to Others Fitzroy, Victoria: AER Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre.

41. Petrie D, Doran C, Shakeshaft A, Sanson-Fisher R. The demand for intensity versus frequency of alcohol consumption: evidence from rural Australia. Dundee Discussion Papers in Economics, University of Dundee, Working paper no. 222, January 2009.

42. Doran CM (2009). Report on the cost-effectiveness analysis of tobacco control in Singapore. Singapore: Health Promotion Board, Ministry of Health.

43. Doran CM (2008). An analysis of, and proposed methodology for, measuring the socio-economic impact of drugs, crime and corruption in the Lao PDR. Vientiane: United Nations Office of Drugs and Crime Lao PDR Regional Office.

44. Vietnam Evidence for Health Policy (VINE) project. Vietnam burden of disease and injury study. School of Population Health, The University of Queensland. Hanoi School of Public Health, Ministry of Health, Vietnam. Brisbane and Hanoi; 2008.

45. Doran CM, Vos T, Cobiac L, Hall W, Asamoah I, Wallace A, Naidoo S, Byrnes J, Fowler G, Arnett K (2008). Identifying cost-effective interventions to reduce the burden of harm associated with alcohol misuse in Australia. Canberra: Alcohol Education Rehabilitation Foundation.

46. DORAN CM, Gasgoine M. The cost of major trauma – Queensland Trauma Plan Project. Brisbane: School of Population Health, University of Queensland, 2005.

47. Shanahan M, Doran C, Gibson A, Stafford J, Mattick RP. Interventions for excessive alcohol use: costs and outcomes of pharmacotherapies and other treatments. Monograph 56.Sydney, National Drug and Alcohol Research Centre, 2005

48. Shanahan M, Shakeshaft A, Fawcett J, Doran C, Mattick RP. Modelling the costs and outcomes of changing general practitioners behaviours with respect to screening for at-risk drinking. Technical Report 219. Sydney, National Drug and Alcohol Research Centre, 2005.

49. Shanahan M, Doran C, Stafford J, Shearer J, Mattick RP. Pharmacotherapies for nicotine dependence: social and economic considerations. NDARC Technical Report, Sydney, National Drug and Alcohol Research Centre, 2004

50. Doran C, Begg S, Vos T, Lopez A. Fiji Burden of Disease from Tobacco. A report prepared on behalf of WHO Fiji Regional Office, Secretariat of the Pacific Communities and the Fiji National Health Research Committee. Brisbane, University of Queensland, 2004.

51. Doran CM. Drug and alcohol treatment: Is it worth it and can we afford it? NDARC Centrelines, 2003.

52. Doran CM, Gates J, Fawcett J, Mattick RP. Characteristics of Australian smokers using Bupropion and Nicotine Replacement Therapies: preliminary results from a computer assisted telephone survey. Pharmacy Guild Review, 2003.

53. Doran CM. An economic impact assessment of NCDs on hospital resources in Tonga, Vanuatu and Kiribati. Prepared for Secretariat of the Pacific Community, 2003.

54. Mattick R, Digiousto E, Doran C, et al. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): Preliminary report of results and recommendations. Prepared for the Inter-Governmental Committee on Drugs, 2001.

55. Mattick R, Digiousto E, Doran C, et al. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): Report of results and recommendations. Prepared for the Ministerial Council on Drug Strategy, July 2001.

56. Beilby J, Bowman J, Donovan J, Doran CM, Kingsland M, Mackson J, O’Connell D, Phillips S, Roughead L, Weekes L. National Prescribing Service Evaluation Report Number 1, 2000.

57. Doran CM, Girgis A, Sanson-Fisher RW, Bonevski B. A cost analysis of mobile mammography screening units in specific rural/remote towns in NSW. A report prepared for the NSW Program for Mammography Screening, 1998.

58. Doran CM. Cost of adolescent smoking in CART and TAP towns: an analysis. A report prepared for the NSW Cancer Council Cancer Education Research Program, 1996. Doran CM. Drug and Alcohol Clinical Services Report. A report prepared for the Hunter Centre for Health Advancement in conjunction with Hunter Health, 1995.

59. Doran CM. Economic Costs of Specific Diseases in NSW and the Hunter Region. A report prepared for the Hunter Centre for Health Advancement, 1995.

· Reviewer for journals: Addiction, Addictive Behaviors, Applied Health Economics and Health Policy, Australian and New Zealand Journal of Public Health, British Medical Journal, Bulletin of the World Health Organisation, Cost-Effectiveness and Research Allocation, Drug and Alcohol Review, Drug and Alcohol Dependence, Expert Review of Pharmacoeconomics and Outcome Research, Journal of American Medical Association, Medical Journal of Australia, New England Journal of Medicine, Nicotine and Tobacco Research, Pharmacoeconomics, Tobacco Control.

· Reviewer for the United Kingdom National Institute for Health Research Evaluation; NHMRC and ARC funding schemes.

· Editorial board for Applied Health Economics and Health Policy and Journal of Addiction and Therapy.

· 2013. Institute of Urban Indigenous Health. Economic impact assessment. Brisbane.

· 2012. Australian Prostate Cancer Research. Economic analysis for a Prostate Cancer Cooperative Research Centre.

· 2011. Victorian Health Promotion Foundation (VicHealth). Strengthening the evidence base for volumetric taxation of alcohol in Australia.

· 2009. Research and Strategic Planning Division, Ministry of Health, Singapore. Economic evaluation of the Singapore tobacco control program.

· 2008. United Nations Office on Drugs and Crime, Laos. To develop a methodology to measure the impact and cost of drugs and crime on the socio-economic development of the Lao PDR.

· 2007. Centre for Complementary Research, University of Western Sydney. Review of approaches to economic analysis of complementary medicine interventions.

· 2007. Atlantic Philanthropies, Vietnam. Health economic expertise related to establishing a Centre of Health Economics in Vietnam.

· 2006. World Health Organisation, Geneva. Systematic review of economic evidence pertaining to treatment for opioid dependence.

· 2005. Reckitt Benckiser, Hull United Kingdom. Assist in Suboxone submission to Pharmaceutical Benefits Advisory Committee. Provide advice of implementing pharmacoeconomic data collection instruments into clinical trials.

· 2004. South Pacific Commission (SPC), New Caledonia. Economic impact assessment of non-communicable diseases in Tonga, Vanuatu and Kiribati